News

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...
MIAMI, April 22, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic ...